Ryan Bitton, PharmD, MBA, and Frank J. Palella, MD, discuss facts about the implementation of USPSTF guidelines for HIV PrEP therapy. Ryan Haumschild, PharmD, MS, MBA: Thank you. It’s such a complex ...
A new Canadian guideline on HIV prevention emphasizes the patient’s role in decisions related to pre-exposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) prescriptions. It also highlighted ...
The Centers for Disease Control and Prevention (CDC) has come out with a strong recommendation for the use of Gilead Sciences’ twice-yearly HIV pre-exposure prophylaxis (PrEP) med Yeztugo, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results